|Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis|
DJ Hicklin, LM Ellis
Journal of clinical oncology 23 (5), 1011-1027, 2005
|Raise standards for preclinical cancer research|
CG Begley, LM Ellis
Nature 483 (7391), 531-533, 2012
|Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases|
EK Abdalla, JN Vauthey, LM Ellis, V Ellis, R Pollock, KR Broglio, K Hess, ...
Annals of surgery 239 (6), 818, 2004
|Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer|
Y Takahashi, Y Kitadai, CD Bucana, KR Cleary, LM Ellis
Cancer research 55 (18), 3964-3968, 1995
|VEGF-targeted therapy: mechanisms of anti-tumour activity|
LM Ellis, DJ Hicklin
Nature reviews cancer 8 (8), 579-591, 2008
|Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients|
SA Curley, F Izzo, P Delrio, LM Ellis, J Granchi, P Vallone, F Fiore, ...
Annals of surgery 230 (1), 1, 1999
|Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis|
G Niu, KL Wright, M Huang, L Song, E Haura, J Turkson, S Zhang, ...
Oncogene 21 (13), 2000-2008, 2002
|The implications of angiogenesis for the biology and therapy of cancer metastasis|
IJ Fidler, LM Ellis
Cell 79 (2), 185-188, 1994
|Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and …|
R Fukuda, K Hirota, F Fan, Y Do Jung, LM Ellis, GL Semenza
Journal of Biological Chemistry 277 (41), 38205-38211, 2002
|Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis|
SA Curley, F Izzo, LM Ellis, JN Vauthey, P Vallone
Annals of surgery 232 (3), 381, 2000
|Simplified staging for hepatocellular carcinoma|
JN Vauthey, GY Lauwers, NF Esnaola, KA Do, J Belghiti, N Mirza, ...
Journal of clinical oncology 20 (6), 1527-1536, 2002
|MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines|
DHF Teng, R Hu, H Lin, T Davis, D Iliev, C Frye, B Swedlund, KL Hansen, ...
Cancer research 57 (23), 5221-5225, 1997
|Pathologic response to preoperative chemotherapy|
D Blazer III, Y Kishi, D Maru, Y Shin Chun, M Overman, D Fogelman, ...
|Antiangiogenic therapy in oncology: current status and future directions|
GC Jayson, R Kerbel, LM Ellis, AL Harris
The Lancet 388 (10043), 518-529, 2016
|Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines|
AD Yang, F Fan, ER Camp, G van Buren, W Liu, R Somcio, MJ Gray, ...
Clinical cancer research 12 (14), 4147-4153, 2006
|Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition|
NA Dallas, L Xia, F Fan, MJ Gray, P Gaur, G Van Buren, S Samuel, ...
Cancer research 69 (5), 1951-1957, 2009
|Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies|
AS Pearson, F Izzo, RYD Fleming, LM Ellis, P Delrio, MS Roh, J Granchi, ...
The American journal of surgery 178 (6), 592-598, 1999
|Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with …|
S Kopetz, PM Hoff, JS Morris, RA Wolff, C Eng, KY Glover, R Adinin, ...
Journal of clinical oncology 28 (3), 453, 2010
|Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts|
MC Prewett, AT Hooper, R Bassi, LM Ellis, HW Waksal, DJ Hicklin
Clinical cancer research 8 (5), 994-1003, 2002
|HIF-1 α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate …|
MJ Gray, J Zhang, LM Ellis, GL Semenza, DB Evans, SS Watowich, ...
Oncogene 24 (19), 3110-3120, 2005